NSCLC: Zwei Positive Studien Zu PD-L1-Hemmer

Im Focus Onkologie
doi 10.1007/s15015-015-2129-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy